Jay S Stout sold $1.5M of Immunovant (IMVT)

Executed Jun 26, disclosed Jun 26, the same day.

Value, as filed

$1.5M

40,000 sh across 2 lots

Executed

Jun 26

the trade date, as filed

Disclosed

Jun 26

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Jay S Stout Chief Technology Officer profile →

Jay S Stout (Chief Technology Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Immunovant, Inc. (IMVT). The largest single filing was $1.5M of IMVT (40,000 sh across 2 lots, as filed), executed Jun 26.

The name

IMVT

Immunovant, Inc. IMVT · Healthcare · 35 filings in 24 months ticker →

Healthcare · Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jay S Stout in IMVT

IMVTSALE Immunovant, Inc. $111K
2,857 sh × $38.69
Exec Jul 23
Filed Jul 24 · 5:57 PM ET IMVTSALE Immunovant, Inc. $214K
8,614 sh × $24.83
Exec Apr 8
Filed Apr 10 · 5:30 PM ET